Y. Xie

Dual inhibition of mTORC1/2 by DCZ0358 induces cytotoxicity in multiple myeloma and overcomes the protective effect of the bone marrow microenvironment.

Weiliang Zhu, Zhijian Xu, Dandan Yu, 2018, Cancer letters.

DCZ0014, a novel compound in the therapy of diffuse large B-cell lymphoma via the B cell receptor signaling pathway.

Weiliang Zhu, Zhijian Xu, Dandan Yu, 2020, Neoplasia.

DCZ3301, a novel cytotoxic agent, inhibits proliferation in diffuse large B-cell lymphoma via the STAT3 pathway

Weiliang Zhu, Gege Chen, Gaomei Chang, 2017, Cell Death & Disease.

Glycolysis is suppressed by DCZ0801-induced inactivation of the Akt/mTOR pathway in Multiple Myeloma

Weiliang Zhu, Zhijian Xu, Jumei Shi, 2020, Journal of Cancer.

Dihydrocelastrol exerts potent antitumor activity in mantle cell lymphoma cells via dual inhibition of mTORC1 and mTORC2.

Weiliang Zhu, Zhijian Xu, Yong Zhang, 2018, International journal of oncology.